Top

Published in:

01-11-2012 | Original article

Osteoconductive action of alendronate after implantation of beta tricalcium phosphate in rat adjuvant-induced arthritis

Authors: Takahiro Netsu, Naoki Kondo, Katsumitsu Arai, Akira Ogose, Naoto Endo

Published in: Journal of Bone and Mineral Metabolism | Issue 6/2012

Abstract

The aim of the study was to determine the effect of alendronate on resorption of β-tricalcium phosphate (β-TCP) and bone formation in rats with adjuvant-induced arthritis (AIA). After preparation of a model of AIA in rats (day 0), alendronate or vehicle was injected intraperitoneally once daily five times in a week. Cylindrical β-TCP was implanted into the rat femoral condyle on day 7. Rats were killed on days 12, 15, and 21, and specimens and serum samples were collected. Specimens were analyzed by tartrate-resistant acid phosphate (TRAP) staining, immunohistochemistry of the ED1 protein, and in situ hybridization with digoxigenin-labeled α1 chain of type I procollagen (COL1A1). Mineralized bone sections were analyzed by Villanueva bone stain. The serum osteocalcin level was measured using an enzyme-linked immunosorbent assay kit. Alendronate decreased the number of TRAP-positive cells attached to β-TCP, the numbers of ED1-positive multinucleated giant cells, and resorption of β-TCP. In AIA rats treated with alendronate, COL1A1 mRNA-positive cells adhered to β-TCP were round or cuboid whereas the cells in untreated AIA rats were fibroblast-like cells. Alendronate increased calcification of newly formed bone whereas it did not restore the bone formation suppressed with inflammation. These results suggest that alendronate has the potential to conduct mature bone after implantation of β-TCP in AIA. Alendronate may help to reduce insufficiency of newly formed bone after implantation of β-TCP in diseases characterized by increased bone resorption such as rheumatoid arthritis.

Ohsawa K, Neo M, Matsuoka H, Akiyama H, Ito H, Kohno H, Nakamura T (2000) The expression of bone matrix protein mRNAs around beta-TCP particles implanted into bone. J Biomed Mater Res 52:460–466PubMedCrossRef

Kondo N, Ogose A, Tokunaga K, Ito T, Arai K, Kudo N, Inoue H, Irie H, Endo N (2005) Bone formation and resorption of highly purified beta-tricalcium phosphate in the rat femoral condyle. Biomaterials 26:5600–5608PubMedCrossRef

Nakagawa N, Saegusa Y, Abe S, Miura Y, Yoshiya S (2006) The effectiveness of RA wrist fusion using beta-TCP without autogenous iliac bone grafting: a report of four cases. Hand Surg 11:71–75PubMedCrossRef

Ozawa M, Tanaka K, Morikawa S, Chazono M, Fujii K (2000) Clinical study of the pure β-tricalcium phosphate—reports of 167 cases (in Japanese). J East Jpn Orthop Traumatol 12:409–413

Takasaki M, Kawamura S, Onizuka T, Honjo N, Kita M (2005) Surgical treatment with β-tricalcium phosphate for periarticular fracture (in Japanese). Seikei geka to Saigai geka (Orthopedics and Traumatology) 54:111–115

Hashimoto J, Nampei A, Hirao M, Tsuboi H, Kuriyama K, Fujii M, Murase T, Myoui A, Yoshikawa H (2009) Rheumasurgery using an artificial bone substitute (in Japanese). Rinsho Seikei Geka (Clinical Orthopaedic Surgery) 44:25–30

Sano H, Arai K, Murai T, Fujisawa J, Kondo N, Netsu T, Hanyu T, Saeki T, Ito T, Endo N (2009) Tight control is important in patients with rheumatoid arthritis treated with an anti-tumor necrosis factor biological agent: prospective study of 91 cases who used a biological agent for more than 1 year. Mod Rheumatol 19:390–394PubMedCrossRef

Tanaka T, Saito M, Chazono M, Kumagae Y, Kikuchi T, Kitasato S, Marumo K (2010) Effects of alendronate on bone formation and osteoclastic resorption after implantation of beta-tricalcium phosphate. J Biomed Mater Res A 93:469–474PubMed

Durai M, Gupta RS, Moudgil KD (2004) The T cells specific for the carboxyl-terminal determinants of self (rat) heat-shock protein 65 escape tolerance induction and are involved in regulation of autoimmune arthritis. J Immunol 172:2795–2802PubMed

10.

Verdrengh M, Holmdahl R, Tarkowski A (1995) Administration of antibodies to hyaluronan receptor (CD44) delays the start and ameliorates the severity of collagen II arthritis. Scand J Immunol 42:353–358PubMedCrossRef

11.

Burstone MS (1958) Histochemical demonstration of acid phosphatase with naphthol AS-phosphate. J Nat Cancer Inst 21:523–539PubMed

12.

Amizuka N, Yamada M, Watanabe J, Hoshi K, Fukushi M, Oda K, Ikehara Y, Ozawa H (1998) Morphological examination of bone synthesis via direct administration of basic fibroblast growth factor into rat bone marrow. Microsc Res Tech 41:313–322PubMedCrossRef

13.

Damoiseaux JG, Döpp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD (1994) Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83:140–147PubMed

14.

Dijkstra CD, Döpp EA, Joling P, Kraal G (1985) The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54:589–599PubMed

15.

Yamagiwa H, Tokunaga K, Hayami T, Hatano H, Uchida M, Endo N, Takahashi HE (1999) Expression of metalloproteinase-13 (collagenase-3) is induced during fracture healing in mice. Bone (NY) 25:197–203

16.

Hayami T, Endo N, Tokunaga K, Yamagiwa H, Hatano H, Uchida M, Takahashi HE (2000) Spatiotemporal change of rat collagenase (MMP-13) mRNA expression in the development of rat femoral neck. J Bone Miner Metab 18:185–193PubMedCrossRef

17.

Takahashi E (1997) Handbook of bone morphology, 2nd edn. Nishimura, Niigata

18.

Neo M, Herbst H, Voigt CF, Gross UM (1998) Temporal and spatial of osteoblast activation following implantation of β-TCP particles into bone. J Biomed Mater Res 39:71–76PubMedCrossRef

19.

Wada T, Hara K, Ozawa H (1989) Ultrastructural and histochemical study of β-tricalcium phosphate resorbing cells in periodontium of dogs. J Periodont Res 24:391–401PubMedCrossRef

20.

Renooij W, Hoogendoorm HA, Visser WJ, Lentferink RHF, Schmitz MGJ, Ieperen HV, Oldenberg SJ, Janssen WM, Akkermans LMA, Wittebol P (1985) Bioresorption of ceramic strontium-85-labeled calcium phosphate implants in dog femora: a pilot study to quantitate bioresorption of ceramic implants of hydroxyapatite and tricalcium orthophosphate in vivo. Clin Orthop 197:272–285PubMed

21.

Eggli PS, Muller W, Shenk RK (1988) Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in cancellous bone in rabbits. Clin Orthop 232:127–138PubMed

22.

Szekanecz Z, Halloran MM, Volin MV, Woods JM, Strieter RM, Kenneth Haines G 3rd, Kunkel SL, Burdick MD, Koch AE (2000) Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum 43:1266–1277PubMedCrossRef

23.

Goldring SR, Goldring MB (2007) Eating bone or adding it: the Wnt pathway decides. Nat Med 13:133–134PubMedCrossRef

24.

Russell RG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19:733–759PubMedCrossRef

25.

Harada H, Nakayama T, Tanaka T, Katsumata T (2004) Effects of bisphosphonates on joint damage and bone loss in rat adjuvant-induced arthritis. Inflamm Res 53:45–52PubMedCrossRef

26.

Van Beek ER, Löwik CW, Papapoulos SE (2002) Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranyl geranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors. Bone (NY) 30:64–70

27.

Hughes DE, MacDonald BR, Russell RG, Gowen M (1989) Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest 83:1930–1935PubMedCrossRef

28.

Löwik CW, van der Pluijm G, van der Wee-Pals LJ, van Treslong-De Groot HB, Bijvoet OL (1988) Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate. J Bone Miner Res 3:185–192PubMedCrossRef

29.

Coxon FP, Thompson K, Roelofs AJ, Ebetino FH, Rogers MJ (2008) Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells. Bone (NY) 42:848–860

30.

Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363–1374PubMedCrossRef

31.

Plotkin LI, Manolagas SC, Bellido T (2006) Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs. Bone (NY) 39:443–452

Title: Osteoconductive action of alendronate after implantation of beta tricalcium phosphate in rat adjuvant-induced arthritis
Authors: Takahiro Netsu
Naoki Kondo
Katsumitsu Arai
Akira Ogose
Naoto Endo
Publication date: 01-11-2012
Publisher: Springer Japan
Published in: Journal of Bone and Mineral Metabolism / Issue 6/2012
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-012-0369-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2012

The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice

Smoking is a predictor of worse trabecular mechanical performance in hip fragility fracture patients

Mean platelet volume is negatively associated with bone mineral density in postmenopausal women

The effect of risedronate (17.5 mg/week) treatment on quality of life in Japanese women with osteoporosis: a prospective observational study

The distribution of FRAX®-based probabilities in women from Japan

Effects of different doses of ferutinin on bone formation/resorption in ovariectomized rats

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials